Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients

May 30, 2017 updated by: Tanta University
Spontaneous bacterial peritonitis (SBP) is an ascitic fluid infection in cirrhotic patients

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Platelet indices can be utilized as a non-invasive predictor of SBP.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt
        • Recruiting
        • Tanta university hospital
        • Principal Investigator:
          • Taher Eldemerdash, Professor
        • Principal Investigator:
          • Abdelrahman Kobtan, Consultant
        • Sub-Investigator:
          • Amal Helmy, Professor
        • Sub-Investigator:
          • Rania Kafoury, Physician
        • Sub-Investigator:
          • Sherief Abd-Elsalam, Consultant

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with cirrhotic ascites

Description

Inclusion Criteria:

  • Cirrhotic patients and ascites

Exclusion Criteria:

  • patients with ascites due to causes other than cirrhosis- immunocompromised patients,
  • patients with abnormal thrombocytes due to non-hepatic causes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cirrhotic ascitic patients with SBP,
Diagnostic test: Platelet indices
MPV, PDW
cirrhotic ascitic patients without SBP,
Diagnostic test: Platelet indices
MPV, PDW
Healthy volunteers
Healthy individuals
Diagnostic test: Platelet indices
MPV, PDW

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with SBP and abnormal platelet indices
Time Frame: 6 months
Number of patients with SBP and abnormal platelet indices
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tanta University

Investigators

  • Principal Investigator: Taher Eldemerdash, Professor, Consultant of Hepatology - Tanta University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2017

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

May 27, 2017

First Submitted That Met QC Criteria

May 30, 2017

First Posted (Actual)

May 31, 2017

Study Record Updates

Last Update Posted (Actual)

May 31, 2017

Last Update Submitted That Met QC Criteria

May 30, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • eldemerdash

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cirrhosis, Liver

Clinical Trials on Platelet indices

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe